Red Light Holland Announces Closing of Final Tranche of Fully Subscribed Private Placement Including Strategic Mutual Investment with PharmaDrug

Shares :


Toronto, Ontario–(Newsfile Corp. – July 16, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has closed the final tranche (the “Final Tranche“) of its previously announced and now fully subscribed private placement (the “Private Placement“) of units (the “RLH Units“). 

The Final Tranche was completed on a non-brokered basis, and was comprised of both cash investors and PharmaDrug Inc. (CSE: BUZZ) (“PharmaDrug“), which entered into a securities exchange agreement with the Company dated July 14, 2020 (the “Securities Exchange Agreement“). The transactions contemplated by the Securities Exchange Agreement, and the Company’s cash investment of $200,000 into PharmaDrug, each closed in accordance with their terms, as more fully described in the Company’s press release of July 15, 2020. In addition, the Company issued a total of 7,147,272 RLH Units to cash investors at a price of $0.165 per RLH Unit. Each RLH Unit consists of one common share in the capital of the Company (a “RLH Share“) and one common share purchase warrant (a “RLH Warrant“) of the Company. Each RLH Warrant entitles the holder to purchase one additional RLH Share at an exercise price of $0.26 at any time until July 16, 2024, subject to an accelerated expiry option. If, following the date that is four months and one day following the date hereof, the volume weighted average trading price of the RLH Shares on the Canadian Securities Exchange (the “CSE“) for any 10 consecutive trading days equals or exceeds $0.50, the Company may, upon providing written notice to the holders of RLH Warrants, accelerate the expiry date of the RLH Warrants to the date that is 30 days following the date of such written notice.

The Company intends to use the net proceeds of the Final Tranche for working capital and general corporate purposes.

All securities issued in the Final Tranche closing are subject to a four-month hold period under applicable securities laws expiring November 17, 2020.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

M2Bio Sciences inc, an opportunity of a lifetime?| LOOK HERE

For more information on the psychedelics market and all the companies involved | HERE

Sign up for MORE news updates !

This article is written and published by The Cannabis Stock

Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies

The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.

Click on a star to rate this article !

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Shares :